Alex Teule (A Teule, Àlex Teulé)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Ejection Fraction

Small Cell Lung Cancer

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Carmen Riesco-Martinez, Jaume Capdevila Castillón, Vicente Alonso, Paula Jimenez-Fonseca, Alex Teule, Enrique Grande, Isabel Sevilla, Marta Benavent, Teresa Alonso-Gordoa, Ana Custodio, Beatriz Anton-Pascual, Jorge Hernando, Eduardo Polo, Oscar Alfredo Castillo-Trujillo, Arantza Lamas-Paz, Ana Teijo-Quintans, Yolanda Rodriguez-Gil, Beatriz Soldevilla, Rocio Garcia-Carbonero
Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913). Nature communications 15 (1) (2024)
Maria Carmen Riesco-Martinez, Jaume Capdevila Castillón, Vicente Alonso, Paula Jimenez-Fonseca, Alex Teule, Enrique Grande, Isabel Sevilla, Marta Benavent, Teresa Alonso-Gordoa, Ana Custodio, Beatriz Anton-Pascual, Jorge Hernando, Eduardo Polo, Oscar Alfredo Castillo-Trujillo, Arantza Lamas-Paz, Ana Teijo-Quintans, Yolanda Rodriguez-Gil, Beatriz Soldevilla, Rocio Garcia-Carbonero
Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913). Nature communications 15 (1) (2024)
Maria Carmen Riesco-Martinez, Jaume Capdevila Castillón, Vicente Alonso, Paula Jimenez-Fonseca, Alex Teule, Enrique Grande, Isabel Sevilla, Marta Benavent, Teresa Alonso-Gordoa, Ana Custodio, Beatriz Anton-Pascual, Jorge Hernando, Eduardo Polo, Oscar Alfredo Castillo-Trujillo, Arantza Lamas-Paz, Ana Teijo-Quintans, Yolanda Rodriguez-Gil, Beatriz Soldevilla, Rocio Garcia-Carbonero
Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913). Nature communications 15 (1) (2024)
Jaume Capdevila Castillón, J Hernando, Alex Teule, C Lopez, R Garcia-Carbonero, M Benavent, A Custodio, Alejandro Garcia-Alvarez, A Cubillo, V Alonso, A Carmona-Bayonas, T Alonso-Gordoa, Guillermo Crespo, P Jimenez-Fonseca, M Blanco, A Viudez, A La Casta, I Sevilla, A Segura, M Llanos, Stefania Landolfi, Paolo G Nuciforo, J L Manzano
Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin. Nature communications 14 (1) (2023)
Núria Dueñas, Matilde Navarro, Alex Teule, Ares Solanes, Mònica Salinas, Sílvia Iglesias, Elisabet Munté, Jordi Ponce Sebastià, Jordi Guardiola, Esther Kreisler, Elvira Carballas, Marta Cuadrado, Xavier Matias-Guiu, Napoleón de la Ossa, Joan Lop Gros, Conxi Lázaro, Gabriel Capellá Munar, Marta Pineda, Joan Brunet
Correction: Dueñas et al. Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals. Cancers 2020, 12, 3419. Cancers 13 (13) (2021)